29 June 2022
ANANDA
DEVELOPMENTS PLC
(“Ananda” or the “Company”)
Completion of
Audit
Further to the Company’s announcement of 10 June 2022, Ananda is pleased to announce that
the audit of the Company’s results for the year ended 31 January 2022 has now been completed.
There are no material changes between the audited results and
the financial information set out in the Company’s 10 June 2022 announcement.
Ananda’s report and accounts for the year ended 31 January 2022 will be available on the
Company’s website at
https://anandadevelopments.com/publications/.
-Ends-
The Directors of the Company accept responsibility for the
contents of this announcement.
ANANDA DEVELOPMENTS
PLC
Chief Executive Officer
Melissa Sturgess
Investor Relations
Jeremy Sturgess-Smith |
+44 (0)7463 686
497
ir@anandadevelopments.com |
PETERHOUSE CAPITAL
LIMITED
Corporate Finance
Mark Anwyl
Corporate Broking
Lucy Williams
Duncan Vasey |
+44 (0)20 7469
0930 |
About Ananda Developments
Ananda is an AQSE-listed medical cannabis company creating
UK-based operations to grow and provide carbon zero, consistent,
medical cannabis for the UK and international markets.
The UK medical cannabis market is predicted to be worth £450m by
2025 and the European market is predicted to be worth USD4.2bn by 2027.
For more information, please visit:
https://anandadevelopments.com/.
Market Abuse Regulation (MAR)
Disclosure
The information contained within this announcement is deemed by
the Company to constitute inside information. Upon the publication
of this announcement via a Regulatory Information Service, this
inside information is now considered to be in the public
domain.
